期刊文献+

Wolman病临床及LIPA基因突变1例

One case with Wolman disease:clinical features and LIPA gene mutation
下载PDF
导出
摘要 目的探讨Wolman病的临床特点及分子诊断的意义。方法对1例符合Wolman病临床表现的患儿进行白细胞溶酶体酸性脂酶LIPA基因测序,分析其突变的类型。结果约5月龄女婴,发现"皮肤黄染10余天,加重伴发热3d"入院。查体见肝脾显著肿大,黄疸。实验室检查提示贫血,肝功能衰竭,高三酰甘油血症;X线胸腹片和腹部增强CT均提示特征性双侧肾上腺增大和广泛钙化。骨髓涂片可见海蓝色泡沫状组织细胞,PAS染色提示脂质沉积。DNA测序显示,LIPA基因编码区第7外显子上发生c.796G>T,p.G266*的纯合无义突变,导致266位甘氨酸(GGA)突变为终止密码(TGA)(p.G266*),致溶酶体酸性脂酶缺失。结论 Wolman病婴儿期起病,以显著肝脾肿大、特征性双侧肾上腺增大和广泛钙化、高三酰甘油血症为特征,相应的酶学分析和LIPA基因检测均可确诊Wolman病。 Objective Wolman disease (WD) is a rare autosomal recessive lysosomal storage disease, caused by deficiency of lysosomal acid lipase (LAL). In China, WD, the same type disorder as cholesteryl ester storage disease ( CESD), but with severe clinical manifestations, is still poorly recognized. The purpose of this study was to investigate the clinical features, genetic abnormality of WD. Methods Clinical manifestations, laboratory examinations, and genetic testing of one case of WD were presented, analyzed, and discussed. The related literatures were reviewed. Results A approximately 5-month-old female infant presented typical WD clinical features, including massive hepatosplenomegaly, remarkable jaundice, liver failure, severe coagulopathy, depressed bone marrow function, bilateral calcified adrenal glands, and in bone marrow aspirate, multiple foamy, vacuolated cytoplasm, sea-blue histiocytes with negative periodic acid schiff staining were observed. Sequencing of the LIPA gene revealed that she was a homozygote with the nonsense mutation ( c. 796G 〉 T) in exon 7, resuhing in the change of amino acid 266 from Gly to termination codon (GGA-TGA). This mutation finally result in a synthesis of the truncated protein ( p. G266 * ). Conclusions The case presented here is the second WD case reported in China's Mainland. Based on the size of our population, WD and CESD are both underestimated. With the progress in DNA sequencing technique, and recognition the nature of WD and CESD, hopefully more cases will be diagnosed and recognized.
出处 《中国循证儿科杂志》 CSCD 2013年第1期55-59,共5页 Chinese Journal of Evidence Based Pediatrics
基金 上海市自然科学基金:12ZR1403500 上海市浦江人才计划:12PJ1401500
关键词 Wolman病 溶酶体酸性脂酶 LIPA基因突变 肝脾大 肾上腺钙化 Wolman disease Lysosomal acid lipase LIPA gene mutation Hepatosplenomegaly Calcification ofadrenal glands
  • 相关文献

参考文献31

  • 1Abramov AS,Schorr S,Wolman M. Generalized xanthomatosis with calcified adrenals[J].AMA J Dis Child,1956,(03):282-286.
  • 2Wolman M,Sterk W,Gatt S. Primary familial xanthomatosis with involvement and calcification of the adrenals[J].Report of two more cases in siblings of a previously described infant Pediatrics,1961.742-757.
  • 3Fitoussi G,Nègre-Salvayre A,Pieraggi MT. New pathogenetic hypothesis for Wolman disease:possible role of oxidized low-density lipoproteins in adrenal necrosis and calcification[J].Biochemical Journal,1994,(Pt 1):267-273.
  • 4Valles-Ayoub Y,Esfandiarifard S,No D. Wolman disease (LIPA p.G87V) genotype frequency in people of Iranian-Jewish ancestry[J].Genet Test Mol Biomarkers,2011,(06):395-398.
  • 5Ho FC,Lin HJ,Chan WC. Wolman's disease:the first reported Chinese patient[J].Modern Medicine of Asia,1978,(11):23-26.
  • 6Wang TR,Chuang SM. A Chinese case of Wolman disease[J].Journal of Inherited Metabolic Disease,1989,(03):328.
  • 7黄永兰,盛慧英,赵小媛,余家康,李乐,刘鸿圣,古聪敏,何登敏,刘丽.Wolman病一例分析及LIPA基因新突变[J].中华儿科杂志,2012,50(8):601-605. 被引量:2
  • 8Sando GN,Rosenbaum LM. Human lysosomal acid lipase/cholesteryl ester hydrolase.Purification and properties of the form secreted by fibroblasts in microcarrier culture[J].Journal of Biological Chemistry,1985,(28):15186-15193.
  • 9Patrick AD,Lake BD. Deficiency of an acid lipase in Wolman's disease[J].Nature,1969,(5198):1067-1068.
  • 10Pagani F,Pariyarath R,Garcia R. New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease[J].Journal of Lipid Research,1998,(07):1382-1388.

二级参考文献21

  • 1Christomanou H, Claudia C. Prenatal monitoring for Wolman's disease in a pregnancy at risk. Hum Genet, 1981,57:440-441.
  • 2Wolman M, Sterk VV, Gatt S, et al. Primary familial xanthomatosis with involvement and calcification of the adrenals. Report of two more cases in siblings of a previously described infant. Pediatrics, 1961,28:742-757.
  • 3Patrick AD, Lake BD. Deficiency of an acid lipase in Wolman's disease. Nature, 1969,222 : 1067-1068.
  • 4Anderson RA, Byrum RS, Coates PM, et al. Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease. Proc Natl Acad Sci U S A, 1994,91:2718-2722.
  • 5Lohse P, Maas S, Sewell AC, et al. Molecular defects underlying Walman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease. J Lipid Res, 1999, 40:221-228.
  • 6Valles-Ayoub Y, Esfandiarifard S, No D, et al. Wolman disease (LIPA p. G87V) genotype frequency in people of Iranian-Jewish ancestry. Genet Test Mol Biomarkers,2011, 15: 395-398.
  • 7Lee TM, Welsh M, Benhamed S, et al. Intragenic deletion as a novel type of mutation in Wolman disease. Mol Genet Metab, 2011,104:703-705.
  • 8Wolman M. Wolman disease and its treatment. Clin Pediatr ( Phila), 1995,34:207-212.
  • 9Tadiboyina VT, Liu DM, Miskie BA, et al. Treatment of dyslipidemia with lavastatin and ezetimibe in an adolesent with cholesterol ester storage disease. Lipids Health Dis,2005,4:26.
  • 10Fasano T, Pisciotta L, Bocchi L, et al. Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease. Mol Genet Metab, 2012,105:450-456.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部